文献速递淋巴瘤

皮下脂膜炎样T细胞淋巴瘤的遗传图谱及HAVCR2突变的临床病理影响

Genetic profiles of subcutaneous panniculitis-like T-cell lymphoma and clinicopathological impact of HAVCR2 mutations.
PubMed 文献 · Blood Adv · 2021-01-01

韩国8家机构53例SPTCL队列中,49例可评估HAVCR2状态,25例(51.0%)携带HAVCR2Y82C。该突变与较年轻年龄(P=.001)、噬血细胞性淋巴组织细胞增生症或类似全身性疾病(P<.001)及较短无复发生存期(P=.023)相关。整合年龄与HAVCR2突变状态的风险分层系统与RFS显著相关(P=.031)。

要点

  • 韩国SPTCL患者中HAVCR2Y82C突变常见,占可评估者的51.0%。
  • HAVCR2Y82C与年轻、HLH或HLH样全身性疾病及短RFS相关。
  • 整合年龄和HAVCR2状态的风险分层系统与RFS显著相关。

核心结论

  • HAVCR2Y82C突变在韩国SPTCL患者中常见,并与独特的临床病理及遗传特征相关。
  • 结合临床病理参数有助于预测SPTCL患者的预后。

研究设计与样本

  • 建立韩国8家机构53例SPTCL患者的全国性队列。
  • 对发现集中8例患者进行全外显子组测序和RNA测序。
  • 在验证集中进行靶向基因测序或HAVCR2直接测序。

主要发现

  • 49例可评估HAVCR2状态的患者中,25例(51.0%)为HAVCR2Y82C。
  • HAVCR2Y82C与较年轻年龄(P = .001)相关。
  • HAVCR2Y82C与噬血细胞性淋巴组织细胞增生症或HLH样全身性疾病发生(P < .001)相关。
  • HAVCR2Y82C与较短无复发生存期(RFS)(P = .023)相关。
  • HAVCR2WT SPTCL中UNC13D、PIAS3和KMT2D突变更频繁,CCR4在mRNA和蛋白水平均显著上调。

关键数值与推荐

  • HAVCR2Y82C SPTCL富集IL6-JAK-STAT3信号和经NF-κB的TNF-α信号相关基因。
  • 整合年龄和HAVCR2突变状态等临床病理特征的风险分层系统与RFS强相关(P = .031)。

临床怎么用

  • 对SPTCL患者可检测HAVCR2Y82C突变以辅助风险分层。
  • 结合年龄和HAVCR2突变状态评估无复发生存期风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Recent studies identified germline mutations in HAVCR2 (encoding T-cell immunoglobulin mucin 3) as a genetic factor that predisposes to subcutaneous panniculitis-like T-cell lymphoma (SPTCL). However, the differences between HAVCR2-mutated (HAVCR2MUT) and HAVCR2 wild-type (HAVCR2WT) SPTCLs remain unclear. A nationwide cohort of 53 patients with SPTCL diagnosed at 8 Korean institutions was established. Whole-exome sequencing and RNA-sequencing were performed on 8 patients in the discovery set. In the validation set, targeted gene sequencing or direct sequencing of HAVCR2 was performed. Of 49 patients with available HAVCR2 status, 25 (51.0%) were HAVCR2Y82C. HAVCR2Y82C was associated with younger age (P = .001), development of hemophagocytic lymphohistiocytosis or hemophagocytic lymphohistiocytosis-like systemic illness (P < .001), and short relapse-free survival (RFS) (P = .023). Most mutated genes in SPTCLs were involved in immune responses, epigenetic modifications, and cell signaling. Mutations in UNC13D, PIAS3, and KMT2D were more frequent in HAVCR2WT SPTCLs. At the gene expression level, HAVCR2Y82C SPTCLs were enriched in genes involved in IL6-JAK-STAT3 signaling and in tumor necrosis factor-α signaling via NF-κB. CCR4 was significantly upregulated in HAVCR2WT SPTCLs both at the messenger RNA level and at the protein level. We established a risk stratification system for SPTCL by integrating clinical and histopathological features, including age and HAVCR2 mutation status. This risk stratification system was strongly associated with RFS (P = .031). In conclusion, the HAVCR2Y82C mutation was common in Korean patients with SPTCL and was associated with unique clinicopathological and genetic features. Combining clinicopathological parameters could aid in predicting prognosis for patients with SPTCL.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Koh J, Jang I, Mun S, et al. Genetic profiles of subcutaneous panniculitis-like T-cell lymphoma and clinicopathological impact of HAVCR2 mutations. Blood Adv. 2021. PMID: 34535012. doi:10.1182/bloodadvances.2021004562

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。